312 related articles for article (PubMed ID: 11802289)
1. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
5. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
7. H1-antihistaminic activity of cetirizine and fexofenadine in allergic children.
Simons FE; J Semus M; Goritz SS; Simons KJ
Pediatr Allergy Immunol; 2003 Jun; 14(3):207-11. PubMed ID: 12787300
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
Ballmer-Weber BK; Gex-Collet C; Wüthrich B
J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
[TBL] [Abstract][Full Text] [Related]
11. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
Meltzer EO; Casale TB; Nathan RA; Thompson AK
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
[TBL] [Abstract][Full Text] [Related]
12. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
Milgrom H; Kittner B; Lanier R; Hampel FC
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
[TBL] [Abstract][Full Text] [Related]
14. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
15. A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis.
Bunnag C; Jareoncharsri P; Tunsuriyawong P; Pumhirun P; Limprasertsiri S; Chochaipanichnon L; Supiyaphun P; Kongpatanakul S
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):127-33. PubMed ID: 11270466
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
17. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
Day JH; Briscoe MP; Clark RH; Ellis AK; Gervais P
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):163-72. PubMed ID: 9291422
[TBL] [Abstract][Full Text] [Related]
18. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis.
Horak F; Stübner P; Zieglmayer R; Kavina A; De Vos C; Burtin B; Donnelly F
Int Arch Allergy Immunol; 2001 May; 125(1):73-9. PubMed ID: 11385291
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
